Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 9456785, 11 pages
https://doi.org/10.1155/2017/9456785
Research Article

Hepatotoxicity in Rats Induced by Aqueous Extract of Polygoni Multiflori Radix, Root of Polygonum multiflorum Related to the Activity Inhibition of CYP1A2 or CYP2E1

School of Chinese Materia Medica, Beijing University of Chinese Medicine, 6 Wang Jing Zhong Huan Nan Lu, Chaoyang District, Beijing 100102, China

Correspondence should be addressed to Zhen-Xiao Sun; moc.liamtoh@ncxznus

Received 1 February 2017; Revised 28 March 2017; Accepted 5 April 2017; Published 24 May 2017

Academic Editor: Antonella Di Sotto

Copyright © 2017 Deng-Ke Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Pharmacopoeia Committee, SP. Pharmacopoeia of the People’s Republic of China, People’s Medical Publishing House, Beijing, China, 2015.
  2. L. Lin, B. Ni, H. Lin et al., “Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review,” Journal of Ethnopharmacology, vol. 159, pp. 158–183, 2015. View at Publisher · View at Google Scholar
  3. M. N. Han, J. M. Lu, G. Y. Zhang, J. Yu, and R. H. Zhao, “Mechanistic studies on the use of polygonum multiflorum for the treatment of hair graying,” BioMed Research International, vol. 2015, Article ID 651048, 8 pages, 2015. View at Publisher · View at Google Scholar
  4. L. Liu, L. Li, L. Zhao et al., “Effects of 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside on learning and memory abilities of rats with chronic cerebral ischemia,” Chinese Journal of Pharmacology and Toxicology, vol. 22, no. 2, pp. 108–115, 2008. View at Google Scholar
  5. W. S. Chen, J. P. Xu, L. Li et al., “Studies on nootropic activity and mechanism of emodin-8-O-β-D-glucopyranoside,” Chinese Traditional and Herbal Drugs, vol. 32, no. 1, pp. 39–41, 2001. View at Google Scholar
  6. R. Zhai, L. S. Lv, and B. Q. Jin, “Hypolipidemic effect of the polysaccharide from polygonum multiflorum,” Food & Machinery, vol. 26, no. 5, pp. 87–101, 2010. View at Google Scholar
  7. Y. Zhu, Y.-G. Li, J.-B. Wang et al., “Causes, features, and outcomes of drug-induced liver injury in 69 children from China,” Gut and Liver, vol. 9, no. 4, pp. 525–533, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Furukawa, S. Kasajima, Y. Nakamura et al., “Toxic hepatitis induced by Show-Wu-Pian, a Chinese herbal preparation,” Internal Medicine, vol. 49, no. 15, pp. 1537–1540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Li, C. Tu, D. Gao et al., “Metabolomic study on idiosyncratic liver injury induced by different extracts of polygonum multiflorum in rats integrated with pattern recognition and enriched pathways analysis,” Frontiers Pharmacology, vol. 07, no. 483, 2016. View at Publisher · View at Google Scholar
  10. G. Danan and R. Teschke, “RUCAM in drug and herb induced liver injury: the update,” International Journal of Molecular Sciences, vol. 17, no. 1, article 14, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Wang, Z. Ma, M. Niu et al., “Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum,” Frontiers of Medicine, vol. 9, no. 4, pp. 457–467, 2015. View at Publisher · View at Google Scholar
  12. X. J. Wang, A. H. Zhang, Y. Han et al., “Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease,” Mol Cell Proteomics, vol. 11, no. 8, pp. 370–380, 2012. View at Publisher · View at Google Scholar
  13. D. Larrey and S. Faure, “Herbal medicine hepatotoxicity: a new step with development of specific biomarkers,” Journal of Hepatology, vol. 54, no. 4, pp. 599–601, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Teschke and A. Eickhoff, “Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps,” Frontiers in Pharmacology, vol. 6, no. 27, 2011. View at Google Scholar
  15. Z. X. Sun and L. Zhang, “Liver damage related to Polygonummultiflorum and its preparation: domestic literature review and analysis,” Adverse Drug Reactions Journal, vol. 12, no. 1, pp. 26–30, 2010. View at Google Scholar
  16. A. Corsini and M. Bortolini, “Drug-induced liver injury: the role of drug metabolism and transport,” The Journal of Clinical Pharmacology, vol. 53, no. 5, pp. 463–474, 2012. View at Google Scholar
  17. A. Ortega-Alonso, C. Stephens, M. I. Lucena, and R. J. Andrade, “Case Characterization, clinical features and risk factors in drug-induced liver injury,” International Journal of Molecular Sciences, vol. 17, no. 5, pp. 10–3390, 2016. View at Google Scholar
  18. T. J. Urban, A. K. Daly, and G. P. Aithal, “Genetic basis of drug-induced liver injury: present and future,” Seminars in Liver Disease, vol. 34, no. 2, pp. 123–133, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Guaoua, I. Ratbi, F. Z. A. Laarabi et al., “Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population,” BMC Genetics, vol. 15, p. 156, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Singla, D. Gupta, N. Birbian, and J. Singh, “Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity,” Tuberculosis, vol. 94, no. 3, pp. 293–298, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Shimada, H. Yamazaki, M. Mimura, Y. Inui, and F. P. Guengerich, “Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drug,” Journal of Pharmacology and Experimental Therapeutics, vol. 270, no. 1, pp. 414–423, 1994. View at Google Scholar
  22. X. He and S. Feng, “Role of metabolic enzymes P450 (CYP) on activating procarcinogen and their polymorphisms on the risk of cancers,” Current Drug Metabolism, vol. 16, no. 10, pp. 850–863, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Carrière, F. Berthou, S. Baird, C. Belloc, P. Beaune, and I. De Waziers, “Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype,” Pharmacogenetics, vol. 6, no. 3, pp. 203–211, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. X. M. Han, X. P. Chen, Q. N. Wu, C. H. Jiang, and H. H. Zhou, “G-2964A and C734A genetic polymorphisms of CYP1A2 in Chinese population,” Acta Pharmacologica Sinica, vol. 21, no. 11, pp. 1031–1034, 2000. View at Google Scholar
  25. M. Kot and W. A. Daniel, “Caffeine as a marker substrate for testing cytochrome P450 activity in human and rat,” Pharmacological Reports, vol. 60, no. 6, pp. 789–797, 2008. View at Google Scholar
  26. M. Martignoni, G. M. Groothuis, and R. d. Kanter, “Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction,” Expert Opinion on Drug Metabolism & Toxicology, vol. 2, no. 6, pp. 875–894, 2006. View at Publisher · View at Google Scholar
  27. M. Umeno, O. W. McBride, C. S. Yang, H. V. Gelboin, and F. J. Gonzalez, “Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression,” Biochemistry, vol. 27, no. 25, pp. 9006–9013, 1988. View at Publisher · View at Google Scholar · View at Scopus
  28. K. F. Ma, X. G. Zhang, and H. Y. Jia, “CYP1A2 polymorphism in Chinese patients with acute liver injury induced by Polygonum multiflorum,” Genetics and Molecular Research, vol. 13, no. 3, pp. 5637–5643, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Li, H. L. Yang, D. K. Li et al., “Study on inhibitory effect of water extract of Polygonum multiflorum on CYP1A2 and CYP2E1 enzymatic activities and mRNA expressions in rat liver,” China Journal of Chinese Materia Medica, vol. 40, no. 7, pp. 1370–1375, 2015. View at Publisher · View at Google Scholar
  30. Z. T. Liang, H. B. Chen, Z. L. Yu, and Z. Z. Zhao, “Comparison of raw and processed Radix Polygoni Multiflori (Heshouwu) by high performance liquid chromatography and mass spectrometry,” Chinese Medicine, vol. 5, no. 29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Zhang, R. C. Zhang, and Z. X. Sun, “Study on the hepatoxicity of polygoni multiflori radix and polygoni multiflori rodix praeparata in rats,” Journal of Chinese Medicinal Materials, vol. 36, no. 9, pp. 1416–1419, 2013. View at Google Scholar · View at Scopus
  32. X. Li, C. Qu, Q. He et al., “Acute hepatitis induced by a Chinese herbal product Qibao Meiran Wan: a case study,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 7, pp. 11624–11627, 2015. View at Google Scholar · View at Scopus
  33. H. Dong, D. Slain, J. Cheng, W. Ma, and W. Liang, “Eighteen cases of liver injury following ingestion of Polygonum multiflorum,” Complementary Therapies in Medicine, vol. 22, no. 1, pp. 70–74, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Zhang, R. C. Zhang, and Z. X. Sun, “Study on the hepatoxicity of polygonimultiflori radix and polygoni multiflorI rodix praeparata in rats,” China Journal of Chinese Materia Medica, vol. 36, no. 9, pp. 1416–1419, 2013. View at Google Scholar
  35. X. Lei, J. Chen, J. Ren et al., “Liver damage associated with Polygonum multiflorum thunb.: a systematic review of case reports and case series,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 459749, 9 pages, 2015. View at Publisher · View at Google Scholar
  36. K. A. Jung, H. J. Min, S. S. Yoo et al., “Drug-induced liver injury: twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum thunb,” Gut and Liver, vol. 5, no. 4, pp. 493–499, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. G.-A. Bounda and Y. Feng, “Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds,” Pharmacognosy Research, vol. 7, no. 3, pp. 225–236, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. R.-C. Zhang, B. Liu, Z.-X. Sun, and D.-Y. Xu, “Effects of extract of Polygonum multiflorum on cell cycle arrest and apoptosis of human liver cell line L02,” Journal of Chinese Integrative Medicine, vol. 8, no. 6, pp. 554–561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Yu, J. Xie, X.-J. Mao et al., “Hepatoxicity of major constituents and extractions of radix polygoni multiflori and radix polygoni multiflori praeparata,” Journal of Ethnopharmacology, vol. 137, no. 3, pp. 1291–1299, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. O. Mueller, H. Stopper, and W. Dekant, “Biotransformation of the anthraquinones emodin and chrysophanol by cytochrome P450 enzymes: bioactivation to genotoxic metabolites,” Drug Metabolism and Disposition, vol. 26, no. 6, pp. 540–546, 1998. View at Google Scholar · View at Scopus
  41. C. Tu, D. Gao, X. Li et al., “Inflammatory stress potentiates emodin-induced liver injury in rats,” Frontiers in Pharmacology, vol. 6, no. 233, 2015. View at Publisher · View at Google Scholar
  42. J. Ma, L. Zheng, Y.-S. He, and H.-J. Li, “Hepatotoxic assessment of Polygoni Multiflori Radix extract and toxicokinetic study of stilbene glucoside and anthraquinones in rats,” Journal of Ethnopharmacology, vol. 162, pp. 61–68, 2015. View at Publisher · View at Google Scholar · View at Scopus